{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:26:29Z","timestamp":1784075189442,"version":"3.55.0"},"reference-count":37,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antioxidants"],"abstract":"<jats:p>Oxidative stress has been shown to play an important role in the development of cataracts. Melatonin is an endogenous hormone that has been proposed to have a protective effect against oxidative stress; however, its association with the risk of cataracts is uncertain. This target trial emulation study aimed to investigate the relationship between the use of melatonin and the risk of cataracts using TriNetX electronic health records from 2015 to 2023. Adults aged 40 years or older who were diagnosed with a sleep disorder and initiated treatment with either melatonin or a hypnotic benzodiazepine (BZD) were included. Patients receiving hypnotic BZD therapy constituted the active comparator group. Propensity score matching (PSM) was performed to control for covariance. Exposure was defined as the initiation of melatonin or hypnotic BZD therapy. The primary outcomes were the incidence of age-related cataracts and other cataract types, assessed using Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). Subgroup and sensitivity analyses were conducted to reduce potential bias. After PSM, 5507 participants were included in each group. Compared with hypnotic BZD users, melatonin users were associated with a significantly lower risk of age-related cataracts (HR, 0.741; 95% CI, 0.681\u20130.807) and other cataracts (HR, 0.503; 95% CI, 0.433\u20130.584). These associations remained consistent across all subgroups and sensitivity analyses. In this target trial emulation cohort study, the use of melatonin was associated with a reduced risk of cataracts, suggesting a potential protective effect that warrants further investigation.<\/jats:p>","DOI":"10.3390\/antiox14081016","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T13:18:14Z","timestamp":1755695894000},"page":"1016","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Melatonin Use and Cataract Risk: A Target Trial Emulation Retrospective Cohort Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-3925","authenticated-orcid":false,"given":"Cheng-Hsien","family":"Hung","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Chang Bing Show Chwan Memorial Hospital, Changhua 50544, Taiwan"},{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0794-9388","authenticated-orcid":false,"given":"Jing-Yang","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Health Policy and Management, Chung Shan Medical University, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-3652","authenticated-orcid":false,"given":"Yu-Chien","family":"Hung","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"},{"name":"School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"},{"name":"Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-4257","authenticated-orcid":false,"given":"Min-Yen","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"},{"name":"Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Cheng-Chung","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan"},{"name":"Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, No. 110, Sec. 1, Jianguo N. Rd., South District, Taichung 40201, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1001\/jamaophthalmol.2016.2627","article-title":"Public Attitudes About Eye and Vision Health","volume":"134","author":"Scott","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0140-6736(22)01839-6","article-title":"Cataracts","volume":"401","author":"Cicinelli","year":"2023","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","article-title":"Trends in prevalence of blindness and distance and near vision impairment over 30 years: An analysis for the Global Burden of Disease Study","volume":"9","author":"Bourne","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","article-title":"A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews","volume":"139","author":"Assi","year":"2021","journal-title":"JAMA Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s10654-018-0450-4","article-title":"Risk of various types of cataracts in a cohort of Mayak workers following chronic occupational exposure to ionizing radiation","volume":"33","author":"Azizova","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/oxfordjournals.epirev.a036197","article-title":"Risk factors for age-related cataracts","volume":"17","author":"Hodge","year":"1995","journal-title":"Epidemiol. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Zhang, Z., Ma, X., Wang, Y.H., Shi, X., and Wei, J.C. (2023). Hydroxychloroquine is neutral on incidental cataracts in patients with rheumatoid arthritis. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-32297-x"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Li, J., Buonfiglio, F., Zeng, Y., Pfeiffer, N., and Gericke, A. (2024). Oxidative Stress in Cataract Formation: Is There a Treatment Approach on the Horizon?. Antioxidants, 13.","DOI":"10.3390\/antiox13101249"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e15237","DOI":"10.1111\/1756-185X.15237","article-title":"Different gender of oxidative balance score on the risk of rheumatoid arthritis in the US population from NHANES","volume":"27","author":"Meng","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e15255","DOI":"10.1111\/1756-185X.15255","article-title":"Association between oxidative balance score and risk of gout: The NHANES cross-sectional study, 2007\u20132018","volume":"27","author":"Meng","year":"2024","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_11","first-page":"CD006757","article-title":"Surgery for cataracts in people with age-related macular degeneration","volume":"2","author":"Casparis","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jama.2021.23652","article-title":"Trends in Use of Melatonin Supplements Among US Adults, 1999\u20132018","volume":"327","author":"Li","year":"2022","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Rusciano, D., and Russo, C. (2024). The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina. Pharmaceuticals, 17.","DOI":"10.20944\/preprints202403.0327.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12430","DOI":"10.1111\/jpi.12430","article-title":"The role and therapeutic potential of melatonin in age-related ocular diseases","volume":"63","author":"Crooke","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lim, J.C., Suzuki-Kerr, H., Nguyen, T.X., Lim, C.J.J., and Poulsen, R.C. (2022). Redox Homeostasis in Ocular Tissues: Circadian Regulation of Glutathione in the Lens?. Antioxidants, 11.","DOI":"10.3390\/antiox11081516"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mi, Y., Wei, C., Sun, L., Liu, H., Zhang, J., Luo, J., Yu, X., He, J., Ge, H., and Liu, P. (2023). Melatonin inhibits ferroptosis and delays age-related cataract by regulating SIRT6\/p-Nrf2\/GPX4 and SIRT6\/NCOA4\/FTH1 pathways. Biomed. Pharmacother., 157.","DOI":"10.1016\/j.biopha.2022.114048"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1076\/0271-3683(200003)2031-9FT225","article-title":"Effect of melatonin against oxidative stress in ultraviolet-B exposed rat lens","volume":"20","author":"Bardak","year":"2000","journal-title":"Curr. Eye Res."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Ren, X., and L\u00e9veillard, T. (2022). Modulating antioxidant systems as a therapeutic approach to retinal degeneration. Redox Biol., 57.","DOI":"10.1016\/j.redox.2022.102510"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1167\/iovs.18-24957","article-title":"Ocular Clocks: Adapting Mechanisms for Eye Functions and Health","volume":"59","author":"Buhr","year":"2018","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cxo.12824","article-title":"Ocular and systemic melatonin and the influence of light exposure","volume":"102","author":"Ostrin","year":"2019","journal-title":"Clin. Exp. Optom."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e12951","DOI":"10.1111\/jpi.12951","article-title":"Melatonin in the mammalian retina: Synthesis, mechanisms of action and neuroprotection","volume":"76","author":"Hicks","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1001\/jamaophthalmol.2024.1822","article-title":"Melatonin and Risk of Age-Related Macular Degeneration","volume":"142","author":"Jeong","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"ref_23","first-page":"2465","article-title":"Melatonin suppresses the long-term risk of cataract surgery in diabetic individuals: An AI based study with clinical corroboration","volume":"64","author":"Monnier","year":"2023","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e2419366","DOI":"10.1001\/jamanetworkopen.2024.19366","article-title":"Cataract Development Among Pediatric Patients with Uveitis","volume":"7","author":"Hsu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/aje\/kwv254","article-title":"Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available","volume":"183","author":"Robins","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e12945","DOI":"10.1111\/jpi.12945","article-title":"Melatonin is a potential novel analgesic agent for osteoarthritis: Evidence from cohort studies in humans and preclinical research in rats","volume":"76","author":"Li","year":"2024","journal-title":"J. Pineal Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40471-015-0053-5","article-title":"The active comparator, new user study design in pharmacoepidemiology: Historical foundations and contemporary application","volume":"2","author":"Lund","year":"2015","journal-title":"Curr. Epidemiol. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"112109","DOI":"10.1016\/j.diabres.2025.112109","article-title":"Impact of sodium-glucose cotransporter-2 inhibitors on ovarian cancer risk in patients with type 2 diabetes mellitus: A multi-institutional TriNetX study","volume":"222","author":"Hung","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e14035","DOI":"10.1111\/jsr.14035","article-title":"The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023","volume":"32","author":"Riemann","year":"2023","journal-title":"J. Sleep Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.2337\/dc13-0263","article-title":"Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin","volume":"36","author":"Marquis","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.03.003","article-title":"The lag-time approach improved drug-outcome association estimates in presence of protopathic bias","volume":"78","author":"Corrao","year":"2016","journal-title":"J. Clin. Epidemiol."},{"key":"ref_33","first-page":"305","article-title":"Melatonin Reduces Cataract Formation and Aldose Reductase Activity in Lenses of Streptozotocin-induced Diabetic Rat","volume":"41","author":"Khorsand","year":"2016","journal-title":"Iran. J. Med. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1269\/jrr.46.277","article-title":"Radioprotective effects of melatonin on radiation-induced cataract","volume":"46","author":"Karslioglu","year":"2005","journal-title":"J. Radiat. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/02713680600899663","article-title":"Use of melatonin to prevent selenite-induced cataract formation in rat eyes","volume":"31","author":"Aydin","year":"2006","journal-title":"Curr. Eye Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"108912","DOI":"10.1016\/j.exer.2021.108912","article-title":"Melatonin counteracts oxidative damage in lens by regulation of Nrf2 and NLRP3 inflammasome activity","volume":"215","author":"Alkozi","year":"2022","journal-title":"Exp. Eye Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"107253","DOI":"10.1016\/j.phrs.2024.107253","article-title":"Melatonin: Unveiling the functions and implications in ocular health","volume":"205","author":"Zhang","year":"2024","journal-title":"Pharmacol. Res."}],"container-title":["Antioxidants"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/8\/1016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:31:34Z","timestamp":1760034694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3921\/14\/8\/1016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["antiox14081016"],"URL":"https:\/\/doi.org\/10.3390\/antiox14081016","relation":{},"ISSN":["2076-3921"],"issn-type":[{"value":"2076-3921","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}